These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 759616)

  • 21. Acute dose-dependent disposition studies of nicotinic acid in rats.
    Iwaki M; Ogiso T; Hayashi H; Tanino T; Benet LZ
    Drug Metab Dispos; 1996 Jul; 24(7):773-9. PubMed ID: 8818575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [GABA-ergic component of the cerebrovascular effects of sodium hydroxybutyrate].
    Mirzoian RS; Gan'shina TS
    Biull Eksp Biol Med; 1981 Oct; 91(10):456-8. PubMed ID: 7317607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of certain GABA-ergic substances on dopamine metabolism in the rat brain].
    Malikova LA; Arefolov VA
    Farmakol Toksikol; 1981; 44(1):37-40. PubMed ID: 6790298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonlinear oral pharmacokinetics of the alpha-antagonist 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline in humans: use of preclinical data to rationalize clinical observations.
    Harrison A; Betts A; Fenner K; Beaumont K; Edgington A; Roffey S; Davis J; Comby P; Morgan P
    Drug Metab Dispos; 2004 Feb; 32(2):197-204. PubMed ID: 14744941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal-fetal pharmacokinetics of methanol.
    Pollack GM; Brouwer KL
    Res Rep Health Eff Inst; 1996 Jun; (74):1-48; discussion 49-53. PubMed ID: 11381741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of nicardipine following oral and intravenous administration in man.
    Graham DJ; Dow RJ; Freedman D; Mroszczak E; Ling T
    Postgrad Med J; 1984; 60 Suppl 4():7-10. PubMed ID: 6527979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat.
    Garrigou-Gadenne D; Burke JT; Durand A; Depoortere H; Thénot JP; Morselli PL
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1283-8. PubMed ID: 2703975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rodent pharmacokinetics and receptor occupancy of the GABAA receptor subtype selective benzodiazepine site ligand L-838417.
    Scott-Stevens P; Atack JR; Sohal B; Worboys P
    Biopharm Drug Dispos; 2005 Jan; 26(1):13-20. PubMed ID: 15578749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of sodium hydroxybutyrate on the ammonia level in the rat muscles under physical exercise].
    Kamysheva VA; Ostrovskaia RU
    Biull Eksp Biol Med; 1980; 89(1):25-7. PubMed ID: 7378564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
    Yang SH; Lee MG
    Int J Pharm; 2007 Mar; 332(1-2):17-23. PubMed ID: 17157458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration.
    Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA
    In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
    Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
    Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.
    Liechti ME; Quednow BB; Liakoni E; Dornbierer D; von Rotz R; Gachet MS; Gertsch J; Seifritz E; Bosch OG
    Br J Clin Pharmacol; 2016 May; 81(5):980-8. PubMed ID: 26659543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous pharmacokinetic profile in rats of etomidate, a short-acting hypnotic drug.
    Lewi PJ; Heykants JJ; Janssen PA
    Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):72-85. PubMed ID: 952578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sodium oxybutyrate concentration in the blood on its repeated use].
    Shifrin GA; Shnol' Via ; Khizhniak AA
    Anesteziol Reanimatol; 1978; (1):19-22. PubMed ID: 345877
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of sodium oxybutyrate, phenamin, transamine and L-dopa on the processes of work capacity recovery under conditions of minimal rest].
    Kurochkin IG; Speranskaia NP
    Farmakol Toksikol; 1975; 38(5):559-62. PubMed ID: 241661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Action of sodium gamma hydroxybutyrate in an insect, Locusta migratoria (Orthoptera)].
    Fuzeau-Braesch S
    Agressologie; 1977; 18(6):301-5. PubMed ID: 613845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.